Scarica l'app Stockscreener
3.75
4.82%
-0.19
Dopo l'orario di chiusura:
3.61
-0.14
-3.73%
Precedente Chiudi:
$3.94
Aprire:
$3.94
Volume 24 ore:
73,018
Relative Volume:
0.77
Capitalizzazione di mercato:
$32.64M
Reddito:
-
Utile/perdita netta:
$-4.69M
Rapporto P/E:
-1.6094
EPS:
-2.33
Flusso di cassa netto:
$-3.81M
1 W Prestazione:
-4.58%
1M Prestazione:
-13.59%
6M Prestazione:
+48.22%
1 anno Prestazione:
+63.04%
Intervallo 1D:
$3.68
$3.9506
Intervallo di 1 settimana:
$3.50
$4.0326
Portata 52W:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Nome
Lixte Biotechnology Holdings Inc
Settore
Industria
Telefono
310 203 2902
Indirizzo
433 PLAZA REAL, BOCA RATON
Confronta LIXT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.75 | 34.29M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie
Can Lixte Biotechnology Holdings Inc. (8640) stock ride next bull market cycleQuarterly Market Review & Technical Buy Zone Confirmation - ulpravda.ru
Will Lixte Biotechnology Holdings Inc. (8640) stock beat revenue estimatesFed Meeting & Low Risk Entry Point Tips - ulpravda.ru
How Lixte Biotechnology Holdings Inc. stock compares to growth peers2025 Biggest Moves & Technical Entry and Exit Tips - ulpravda.ru
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
LIXTE Biotechnology Holdings (LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - Yahoo Finance
Lixte Biotechnology Expands Ovarian Cancer Trial with MD Anderson and GSK - citybuzz -
Will Lixte Biotechnology Holdings Inc. stock benefit from infrastructure spending2025 Volume Leaders & AI Driven Stock Reports - ulpravda.ru
Lixte Biotechnology files to sell 5.26M shares of common stock, warrants - MSN
How strong is Lixte Biotechnology Holdings Inc. Equity Warrant stock revenue growth2025 Trade Ideas & Entry Point Strategy Guides - ulpravda.ru
Lixte Biotechnology announces new registered direct offering - MSN
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - financial-news.co.uk
Breakout Zone: Why Lixte Biotechnology Holdings Inc. stock is a value investor pickJuly 2025 Weekly Recap & Real-Time Market Sentiment Reports - ulpravda.ru
Can Lixte Biotechnology Holdings Inc. stock continue upward trendEarnings Forecast Updates & High Yield Trading Growth - ulpravda.ru
Lixte Biotechnology Holdings (NASDAQ: LIXT) Announces $4.3M Registered Direct Offering Priced at Market - Digital Journal
LIXTE Biotechnology Advances Novel Cancer Treatment Platform Through Clinical Trials and Strategic Moves - citybuzz -
Lixte Biotechnology Holdings Secures $4.3 Million in Registered Direct Offering to Advance Cancer Drug Development - citybuzz -
About Us | Oil & Gas JournalLIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is ‘One to Watch’ - FinancialContent
About Us - FinancialContent
Will Lixte Biotechnology Holdings Inc. (8640) stock deliver compounding returns2026 world cup usa national team quarterfinals young talents transition play winner prediction breakdown - ulpravda.ru
Aug Decliners: Why Lixte Biotechnology Holdings Inc. (8640) stock is listed among top recommendationsInsider Buying & Weekly Momentum Stock Picks - moha.gov.vn
Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuation2026 world cup usa national team qualification midfield engines transition play winner prediction preview - ulpravda.ru
What analysts say about Lixte Biotechnology Holdings Inc 8640 stockCandlestick Trading Patterns & High Return Stock Picks - earlytimes.in
What analysts say about SBCWW stockTechnical Breakout Signals & Free Wealth Planning Blueprints - earlytimes.in
Should You Add Aster DM Healthcare Limited Stock to Your Portfolio NowResistance Breakout Alerts & Minimal Capital Growth - earlytimes.in
Lixte Simplifies Capital Structure via Share Exchange Deal - TipRanks
Price Clustering Detected in Anupam Finserv Limited StockLong-Term Investment Plans & Low Risk High Yield - bollywoodhelpline.com
Will Lixte Biotechnology Holdings Inc. stock see insider buyingTake Profit Strategies & Low Entry Investment Portfolio - Bollywood Helpline
LIXTE expands clinical trial for ovarian cancer treatment By Investing.com - Investing.com Australia
Lixte Expands LB-100 Ovarian Cancer Trial Collaboration - TipRanks
Lixte expands LB-100 ovarian cancer trial collaboration - MSN
Key facts: Lixte Biotechnology secures $4.3M funding; expands cancer collaboration - TradingView — Track All Markets
LIXTE expands clinical trial for ovarian cancer treatment - Investing.com
Lixte Biotechnology Holdings expands collaboration with University of Texas MD Anderson Cancer Center & GSK for LB-100 - marketscreener.com
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial - InvestorNews
Experimental ovarian cancer trial doubles the number of patients it will enroll - Stock Titan
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering - Investing.com Nigeria
Lixte Biotechnology Announces New Registered Direct Offering - TipRanks
Lixte Biotechnology Signs Multiple Material Agreements - TradingView — Track All Markets
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering By Investing.com - Investing.com South Africa
Lixte Biotechnology stock falls after $4.3 million direct offering - Investing.com
Lixte Biotechnology stock falls after $4.3 million direct offering By Investing.com - Investing.com Canada
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering - The Manila Times
Will Lixte Biotechnology Holdings Inc. stock keep outperforming rivalsJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда
Whale Trades: Is Lixte Biotechnology Holdings Inc. Equity Warrant stock a contrarian buyMarket Growth Report & Entry and Exit Point Strategies - Улправда
Profit Recap: What sentiment indicators say about Lixte Biotechnology Holdings Inc stockJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - moha.gov.vn
Can Lixte Biotechnology Holdings Inc. Equity Warrant stock deliver consistent earnings growthPortfolio Gains Report & Fast Momentum Entry Tips - Улправда
What Wall Street predicts for Lixte Biotechnology Holdings Inc. Equity Warrant stock pricePortfolio Return Report & Daily Profit Maximizing Trade Tips - Улправда
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock a contrarian buyTrade Risk Summary & Weekly Market Pulse Alerts - Улправда
Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesInsider Buying & Expert Approved Trade Ideas - Улправда
Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):